alprazolam has been researched along with arachidonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardini, R; Brucke, T; Calogero, AE; Chrousos, GP; Ehrlich, YH; Gold, PW | 1 |
| Ehrlich, YH; Kornecki, E; Lenox, RH | 1 |
2 other study(ies) available for alprazolam and arachidonic acid
| Article | Year |
|---|---|
The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat.
Topics: Adrenocorticotropic Hormone; Alprazolam; Animals; Arachidonic Acid; Arachidonic Acids; Central Nervous System; Corticosterone; Corticotropin-Releasing Hormone; Diterpenes; Ginkgolides; Hypothalamo-Hypophyseal System; Hypothalamus; Lactones; Male; Pituitary Gland; Pituitary-Adrenal System; Platelet Activating Factor; Rats; Rats, Inbred Strains; Verapamil | 1989 |
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
Topics: Adenosine Diphosphate; Alprazolam; Anti-Anxiety Agents; Arachidonic Acid; Arachidonic Acids; Benzodiazepines; Blood Platelets; Calcimycin; Chromatography, Gel; Collagen; Epinephrine; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombin; Triazolam | 1984 |